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1607-551X/Copyright ª 2015, KaohsiuAbstract Ischemia-reperfusion injury can cause renal damage, and phosphodiesterase inhib-
itors are reported to regulate antioxidant activity. We investigated the prevention of renal
damage using tadalafil after renal ischemia reperfusion (I/R) injury in rats. A total of 21 adult
male Wistar albino rats were randomly divided into three groups of seven, including Group 1-
control, Group 2-I/R, and Group 3-tadalafil þ I/R group (I/R-T group) received tadalafil intra-
peritoneally at 30 minutes before ischemia. Inducible nitric oxide synthase, endothelial nitric
oxide synthase, malondialdehyde, and total antioxidant capacity levels were evaluated, and
histopathological changes and apoptosis in the groups were examined. Tadalafil decreased
malondialdehyde levels in the I/R group and increased the total antioxidant capacity level.
Histopathological and immunohistochemical findings revealed that tadalafil decreased renal
injury scores and the ratios of injured cells, as measured through apoptotic protease activating
factor 1, inducible nitric oxide synthase, and endothelial nitric oxide synthase levels. We sug-
gest that tadalafil has protective effects against I/R-related renal tissue injury.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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Tadalafil prevents renal injury 455IntroductionRenal ischemia leads to the depletion of cellular energy,
accumulation of intracellular sodium, calcium, reactive
oxygen species (ROS), and activation of multiple enzyme
systems, including proteases, nitric oxide synthases (NOSs),
phospholipases, and endonucleases; these result in cell
damage and death [1]. Following reinstitution of blood
flow, the final stage of injury occurs during reperfusion,
called reperfusion injury (I/R injury). I/R injury is an im-
mediate nonspecific inflammatory response [2].
Nitrogen oxide (NO) is an important mediator of the
physiological and pathological processes during renal I/R
injury [1,2]. Renal reperfusion following ischemia activates
NOS and increases its expression [3]. Phosphodiesterase
type 5 (PDE5) inhibitors, such as sildenafil, tadalafil, and
vardenafil, comprise the first-line therapy for treating
erectile dysfunction in males. Inhibiting phosphodiesterase
also decreases renal injury [4e7].
In this study, we investigated the effect of tadalafil on
renal I/R injury.
Methods
This study was approved by the Ethics Council of Bu¨lent
Ecevit University Medical Faculty, Zonguldak, Turkey.
Twenty-one Wistar albino rats (weight, 400e450 g) were
divided into three groups. General anesthesia was admin-
istered with 40 mg/kg ketamine hydrochloride (Ketalar,
Eczacıbas‚ı, Turkey) with intraperitoneal injection. An
approximate 3 cm skin incision was made in the abdominal
region. The groups were divided as the following. Group 1,
Control group: No treatment was given. The abdominal
median laparotomy was conducted, blood was taken, and a
bilateral nephrectomy was performed. Group 2, I/R group:
The right kidney pedicle was clamped for 1 hour with a
nontraumatic microvascular clamp (bulldog clamp), and the
kidney was subjected to ischemia. No clamp was put on the
left kidney pedicle. Following ischemia, the right kidney
pedicle clamp was removed, and the kidney was perfused
for 1 hour. Blood was then taken, and a bilateral nephrec-
tomy was performed. Group 3, Tadalafil þ I/R group (I/R-T
group): Before subjecting the rat to ischemia, a 1 mL sus-
pension of 10 mg/kg tadalafil was injected intraperitone-
ally. Then, the right kidney pedicle was clamped for 1 hour,
as described for the I/R group. Following ischemia, the
right kidney was subjected to 1-hour reperfusion by
removing the clamp from the right kidney pedicle. Blood
was then collected, and a bilateral nephrectomy was
performed.
Tissue sampling
At the end of the experiment, the blood samples were
centrifuged at 500g for 3 minutes and stored at 80C for
biochemical evaluation of malondialdehyde (MDA) and total
antioxidant capacity (TAC).
After cutting each kidney into two parts, one part was
stored at 80C for biochemical evaluations, and the other
was fixed in 10% formalin for histological studies.Biochemical analyses
Preparation of tissue samples
Tissues were homogenized on ice with an homogenizer
(Ultra Turrax Type T25-B, IKA Labortechnic, Germany) by
adding 0.1M Tris-hydrochloride buffer solution including
0.1% Tween 80 [8]. Then, the homogenates were centri-
fuged at 800g and 4C. Protein concentrations of superna-
tants were assessed using the Lowry et al [9] method.
MDA working procedure
Serum and tissue MDA levels were evaluated with high-
performance liquid chromatography (HPLC) using an Agilent
1200 HPLC (Agilent Technologies, Munchen, Germany). MDA
was measured using commercial immunodiagnostic kits
(Merck, Bensheim, Germany). Solutions of 1,1,3,3-tetra-
ethoxypropane (TEP), trichloroacetic acid, 2-thiobarbituric
acid, and dinitrophenylhydrazine (DNPH), sodium hydroxide,
perchloric acid, hydrochloric acid, sulfuric acid, methanol,
and ethanol were obtained from Merck (Frankfurter, StraBe
250, Germany). Acetonitrile was obtained from Sigma-Aldrich
(Frankfurter, StraBe 250, Germany). Fifty mL of 6M sodium
hydroxidewas added to 0.250mL serumand then incubated in
a 60

C water bath for an hour. The hydrolyzed sample
(0.125mL) was acidified with 0.125mL of 35% (v/v) perchloric
acid. After centrifugation (500g) for 10 minutes, 0.250 mL su-
pernatant was mixed with 25 mL of 5mM DNPH solution and
incubated in dark for half an hour. One hundred mL of the re-
action mixture was directly injected into HPLC system [10].
MDAstandardwaspreparedbydissolving 25mLTEPin100mLof
water to give a 1mM stock solution. Working standard was
prepared by dilution of 1 mL stock solution in 50 mL of 1%
sulfuric acid and incubation for 2 hours at room temperature.
The resulting MDA standard of 20 mmol/L was further diluted
with 1% sulfuric acid to yield different concentration. The
0.250 mL of standard was mixed with 25 mL DNPH solution and
incubated in dark for 30 minutes. One hundred microlitres of
the reaction mixture was directly injected into HPLC system.
The analytical column was 125 mm 4 mmODS-2 C18 reserve
phase column with particle size of 5 mm (Thermo, Theale/
Berkshire, UK). The mobile phase was acetonitrile-distilled
water (34:66, V/V) containing 0.2% (V/V) acetic acid. All sep-
arations were performed at isocratic conditions with a flow
rate of 1mL/min.MDApeaksweredetermined according to its
retention timeandconfirmedby spikingwithaddedexogenous
standard. Concentrations of MDA were calculated from stan-
dard curve prepared from TEP.
The detection limit of this procedure was 0.15mM and
linearity was 100mM.
TAC working procedure
The TAC measurement principle is based on the reaction of
antioxidants with hydrogen peroxide in the sample. The
antioxidants sample was taken, with the same amount of
hydrogen peroxide. Antioxidants in the sample bind to the
hydrogen peroxide, and the increased hydrogen peroxide
converts TMB (3,30,5,50-tetramethylbenzidine) to a colored
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colored compound is assayed with a photometric proce-
dure. The kit uses a double-antibody sandwich enzyme-
linked immunosorbent assay to determine the amount of
human TA in a biological sample (MyBioSource, San Diego,
CA, USA).
According to the standards’ concentration and the cor-
responding optical density values, the standard curve linear
regression equation was calculated, and then applied to the
optical density values of the sample on the regression
equation to calculate the corresponding sample’s
concentration.
TMB is a noncarcinogenic substitute (Ames test negative)
for benzidine1, suitable as a peroxidase substrate for use in
enzyme-linked immunosorbent assay procedures. The sub-
strate produces a soluble end product that is pale blue in
color and can be read spectrophotometrically at 370 nm or
620e650 nm. The TMB reaction may be stopped with 2M
sulfuric acid (resulting in a yellow color), and read at 450 nm.
Pathological evaluations
Histomorphological evaluation
The hematoxylin and eosin stained sections were evaluated
for histological changes, such as loss of the nucleus, cell
swelling, cytoplasmic vacuolization, brush border loss,
tubular dilatation, hyaline caste formation in the tubular
lumen, and interstitial congestion, and edema in the kidney
tubules. A semiquantitative evaluation of the histopatho-
logical changes in the kidney tubules was carried out ac-
cording to the following criteria: 0Z no change; 1Z change
of 0e10%; 2 Z change of 11e25%; 3 Z change of 26e50%;
4Z change of 51e75%; and 5Z change of 76e100%.
Immunohistochemical evaluation
Cytoplasmic staining for inducible nitric oxide synthase
(iNOS), endothelial NOS (eNOS), and apoptotic protease
activating factor 1 (APAF-1) was performed, and the ratio of
immunopositive cells to the total number of tubular cells
was evaluated. A semiquantitative evaluation according to
staining intensity was carried out according to the following
criteria: 0Z no staining; 1Z minimal; 2Z moderate; and
3 Z strong staining.
The semiqualitative evaluation was performed according
to the following criteria based on the rate of immunopositiveTable 1 Renal tissue and blood levels of malondialdehyde (mm
Right kidney MDA
Group control (n Z 7) 2.71  1.37*,**
Group I/R (n Z 7) 6.30  3.03
Group I/R-T (n Z 7) 5.06  2.11
Data are presented as mean  standard deviation.
*p < 0.05 (Group control vs. Group I/R), ManneWhitney U test.
**p < 0.05 (Group control vs. Group I/R-T), ManneWhitney U test.
***p < 0.05 (Group I/R-T vs. Group I/R), ManneWhitney U test.
I/R Z ischemia/reperfusion; MDA Z malondialdehide; T Z tadalafil.cells: 0 Z no reaction; 1 Z 1e9% of the cells reacted;
2Z 10e49% of the cells reacted; and 3Z  50% of the cells
reacted.
The statistical analyses were carried out using SPSS 16.0
software (SPSS Inc., Chicago, IL, USA). The ManneWhitney
U test was used to compare the tissue and blood MDA and
TAC levels, as well as the histopathological and immuno-
histochemical scores of the groups. A value of p < 0.05
indicated statistical significance.Results
MDA values
Right kidney tissue MDA levels were significantly increased
in the I/R group versus the control group (p Z 0.011;
Table 1).
The right kidney tissue MDA values were significantly
higher in the I/R-T group than those in the control group
(p Z 0.026). However, no significant difference was
observed between I/R group and I/R-T group (p > 0.05;
Table 1).
Tissue MDA values in the left kidney were not different
among the three groups (p > 0.05; Table 1).
Blood MDA levels in the control group were significantly
lower than those in both the I/R (p Z 0.001) and I/R-T
groups (p Z 0.001). Blood MDA levels in the I/R-T group
were significantly lower than those in the I/R group
(p Z 0.017; Table 1).TAC values
TAC levels in right kidneys of the I/R group were signifi-
cantly lower than those in the control group (p Z 0.038).
However, no differences were observed between the I/R-T
and control groups for right kidney tissue (p > 0.05;
Table 2).
Additionally, no differences were observed in the TAC
values of the left kidney among the groups (p > 0.05;
Table 2).
Blood TAC values in the I/R group were significantly
lower than those in the control group (p Z 0.026). No sig-
nificant difference was found between the I/R-T group and
the control group (p > 0.05); however, TAC levels were
significantly higher in the I/R-T group compared with the I/
R group (p Z 0.026; Table 2).ol/g tissue).
Left kidney MDA Blood MDA
2.36  1.79 1.01  0.61*,**
3.91  3.24 7.53  1.71
1.98  0.47 4.72  1.79***
Table 2 Renal tissue and blood sample total antioxidant capacity (mmol/g tissue).
Right kidney TAC Left kidney TAC Blood TAC
Group C (n Z 7) 59.41  34.15* 39.20  20.88 342.29  31.12*
Group I/R (n Z 7) 30.61  7.77 26.08  18.02 265.29  76.99
Group I/R-T (n Z 7) 61.97  58.48 58.64  45.89 339.57  23.59**
Data are presented as mean  standard deviation.
*p < 0.05 (Group C vs. Group I/R), ManneWhitney U test.
**p < 0.05 (Group I/R-T vs. Group I/R), ManneWhitney U test.
C Z control; I/R Z ischemia-reperfusion; T Z tadalafil; TAC Z total antioxidant capacity.
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The right kidneys of five rats in the I/R group had histo-
pathological change levels of 51e75% and two had levels of
76e100%. Histopathological changes, such as loss of the
nucleus, cell swelling, cytoplasmic vacuolization, brush
border loss, tubular dilatation, hyaline cast formation,
interstitial congestion, and edema in tubular structures,
were observed.
The structural histopathological changes in the I/R group
were significantly different compared with those in the
control group (p Z 0.01).
Significant histopathological structural defects were
observed in the I/R-T group compared with those in the
control group (p Z 0.001). However, the damage was
significantly less in the I/R-T group compared with the I/R
group (p Z 0.026; Figure 1).Figure 1. Histopathological changes in right-sided kidney tubu
cytoplasmic vacuolization, brush border loss, tubular dilatation (
congestion, and edema. (B) I/R-T group: decreased histopatholo
Hematoxylin and eosin stain: (A)  200; (B)  100; (C)  200. I/RImmunohistochemical findings
A minimal degree of cytoplasmic staining for iNOS, eNOS,
and APAF-1 was observed in bilateral kidneys of the control
group and the left kidneys in the I/R and I/R-T groups
(Table 3).
The right kidneys in the I/R group showed moderate
cytoplasmic staining for APAF-1 in six kidneys and strong
staining in one kidney, moderate iNOS staining in six kid-
neys, and minimal staining in one kidney, and minimal
staining for eNOS in all kidneys.
All right kidneys in the I/R-T group showed moderate
staining for APAF-1; there was minimal staining for eNOS in
one kidney and moderate staining in six kidneys.
The tubular cells in the right-side kidneys showed
significantly higher cytoplasmic staining for APAF-1 in the I/
R group and I/R-T group than in the control grouples. (A) I/R group: loss of nuclei, cell swelling (thick arrow),
arrow head), hyaline cast formation (thin arrow), interstitial
gical changes. (C) Control group: normal renal parenchyma.
Z ischemia reperfusion; T Z tadalafil.
Table 3 Cytoplasmic staining for apoptotic protease activating factor-1, inducible nitric oxide synthase, and endothelial nitric
oxide synthase.
Group Right kidney Left kidney
APAF-1 iNOS eNOS APAF-1 iNOS eNOS
Control (n Z 7) 0.71  0.48*,** 1.14  0.37* 1.28  0.48* 1.00 1.00 1.00
I/R (n Z 7) 2.57  0.53 1.85  0.37 2.57  0.53 1.00 1.14  0.37 1.00
I/R-T (n Z 7) 1.71  0.48*** 1.00  0.00*** 1.71  0.48*** 1.00 1.00 1.00
Data are presented as mean or mean  standard deviation.
*p < 0.05 (Group control vs. Group I/R), ManneWhitney U test.
**p < 0.05 (Group control vs. Group I/R-T), ManneWhitney U test.
***p < 0.05 (Group I/R-T vs. Group I/R), ManneWhitney U test.
APAF-1 Z apoptotic protease activating factor-1; eNOS Z endothelial nitric oxide synthase; iNOS Z inducible nitric oxide synthase.
Figure 2. Apoptotic protease activating factor-1 immunostaining for apoptosis in right-sided kidney tubules. (A) I/R group: strong
cytoplasmic staining. (B) I/R-T group. (C) Control group: minimal cytoplasmic staining. Biotin-streptavidin peroxidase system,
diaminobenzidine: (A)  200; (B)  200; (C)  200. I/R Z ischemia reperfusion; T Z tadalafil.
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the I/R-T group was lower than that in the I/R group
(p Z 0.026; Figure 2, Table 3).
The tubular cells in the right-side kidneys showed higher
cytoplasmic staining for iNOS in the I/R group than that in
the control group (p Z 0.026; Figure 3, Table 3).
No differences were observed between the control
group and I/R-T group (p > 0.05).
Cytoplasmic staining scores for iNOS in the I/R-T group
were lower than those in the I/R group (p Z 0.004).
Cytoplasmic staining for eNOS was lower in the control
group than that in the I/R group (p Z 0.004); however, no
difference was observed between the I/R-T group and
control group (p > 0.05). Cytoplasmic staining for eNOS in
the I/R-T group was lower than that in the I/R group
(p Z 0.026; Figure 4, Table 3).Immunopositive tubular cell rates
INOS immunoreactivity in tubular cell structures of the left-
sided kidneys in the I/R group revealed six kidneys with a
rate of 1e9% and one with a rate of 10e49%. For eNOS, five
left-sided kidneys had a rate of 1e9%, and two had a rate of
10e49%. All left-sided kidneys in the I/R group showed a
1e9% APAF-1 staining rate.
INOS immunoreactivity in tubular cell structures in the I/
R-T group revealed five left-sided kidneys with a rate of
1e9% and two with a rate of 10e49%. All left-sided kidneys
in the I/R-T group exhibited a 1e9% APAF-1 staining rate.
The ratio of immunopositive cells in tubular structures of
right-sided kidneys was also evaluated. INOS immunoreac-
tivity in tubular cell structures in right-sided kidneys of the
I/R group revealedfive kidneyswith a rate of 10e49%and two
Figure 3. Endothelial nitric oxide synthase immunostaining in right-sided kidney tubules. (A) I/R group: strong cytoplasmic
reaction. (B) I/R-T group. (C) Control group: minimal cytoplasmic reaction. Biotin-streptavidin peroxidase system,
diaminobenzidine: (A)  200; (B)  200; (C)  200. I/R Z ischemia reperfusion; T Z tadalafil.
Figure 4. Inducible nitric oxide synthase immunostaining in right-sided kidney tubules. (A) I/R group: strong cytoplasmic
staining. (B) I/R-T group. (C) Control group: minimal cytoplasmic staining. Biotin-streptavidin peroxidase system, dia-
minobenzidine: (A)  200; (B)  200; (C)  200. I/R Z ischemia reperfusion; T Z tadalafil.
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neys had a rate of 10e49%, and five kidneys had rates 50%.
By contrast, APAF-1 immunoreactivity in right-sided
kidney tissues in the I/R-T group showed a rate of 1e9%
in two kidneys and 10e49% in five kidneys. INOSimmunoreactivity in right-sided kidney tissues in the I/R-T
group revealed that three kidneys had a rate of 1e9% and
four kidneys had a rate of 10e49%. For eNOS, 10e49%
immunopositive tubular cell structures were observed in all
right-sided kidneys.
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rates of APAF-1, iNOS, and eNOS, was observed between
left- and right-sided kidneys (p > 0.05, Table 3).
The APAF-1 immunopositive tubular cell ratio in the
right-sided kidneys in the I/R group was significantly higher
than that in the control group (p Z 0.002). Also it was
reduced significantly in I/R-T group (p Z 0.038) compared
with the I/R group (Table 3).
The iNOS immunopositive tubular cell ratios in right-
sided kidneys in the I/R group were significantly higher than
those in the control group (p Z 0.002). No difference was
observed in the iNOS immunopositive tubular cell ratio
between the control group and I/R/-T groups (p > 0.05,
Table 3).
The eNOS immunopositive tubular cell ratios were
significantly higher (p Z 0.026) in the I/R group compared
with those in the control group and it was lower in I/R-T
group compared with those in the I/R group (p Z 0.026,
Table 3).Discussion
Reperfusion following renal ischemia may cause acute
inflammation and secondary tissue damage. Development
of ROS at this stage may increase damage. Endogenous
antioxidant enzymes exert protective effects on cells by
decreasing the effects of ROS. The amounts of these en-
zymes differ depending on the severity of the oxidative
stress [3]. In particular, vascular endothelial damage de-
velops during renal ischemia [1,2]. While NO is released by
the renal vascular endothelium and the balance between
NO and endothelin-1 is shifted. This decreases the elasticity
of the renal vascular endothelium and thus increases
vascular resistance [2]. NO is a mediator that acts through
cyclic guanosine monophosphate (cGMP) [6,7,11].
Several studies have examined the effect of PDE5 in-
hibitors on renal I/R damage. Chintala et al [11] investi-
gated the antithrombin effect of zaprinast, a PDE5
selective inhibitor, in rats treated with I/R. Guan et al [4]
showed that zaprinast increases renal blood flow by stim-
ulating intracellular cGMP in rats undergoing kidney failure.
Liedo-Garcia et al [6] observed that kidneys recover during
the early post-transplant period with warm ischemia.
Oruc¸ et al [5] reported that when sildenafil is adminis-
tered to I/R damaged kidneys during the ischemic phase, I/
R damage was corrected due to reduced leukocyte infil-
tration. Vardenafil also plays a protective role in I/R dam-
age; however, few studies have addressed the effects of
tadalafil on I/R damage [12,13]. Tadalafil is a vasoactive
agent used to treat erectile dysfunction that has a different
chemical structure than sildenafil and vardenafil [14,15].
Tadalafil reaches maximum plasma concentration in 2
hours, and its plasma half-life is four-fold longer (17.5
hours) than those of sildenafil and vardenafil (4 hours)
[15e17]. Because of this prolonged effect, it is considered
more advantageous for lowering vascular resistance and
treating ischemia.
Antiapoptotic properties of PDE5 inhibitors have been re-
ported [18]. Because sildenafil inhibits apoptosis by increasing
cytochrome-c secretion and the Bcl-2/Bax ratio through NO
[19], tadalafil may work through the same mechanisms.Akgu¨l et al [18] evaluated the effects of sildenafil, var-
denafil, and tadalafil on renal apoptosis in a unilateral
ureteral obstruction model. They determined that all three
PDE5 inhibitors were effective in reducing the number of
apoptotic cells [18]. In our study, the significantly lower
APAF-1 level in the I/R-T group supports this finding.
The role of NO in renal damage remains debatable. NO
exerts both proapoptotic and antiapoptotic effects [18],
depending on the conditions. In previous studies, iNOS and
eNOS expression were reported to increase during testic-
ular ischemia reperfusion, and administration of tadalafil
reduced this increase [20e24]. Increased iNOS and eNOS
expression causes a rise in NO to toxic levels, resulting in
testicular germ cell apoptosis [20,25].
Experimental studies have shown that high NO produc-
tion leads to peroxynitrite formation. Peroxynitrite, a
potent and aggressive cellular oxidant agent, causes the
formation of 3-nitro-L-tyrosine [26].
Choi et al [27] reported that sildenafil lowers renal I/R
damage by increasing iNOS and eNOS levels and maintaining
NO at a particular level. Though this finding contradicts the
findings in our study, it suggests that NO is protective at
normal levels but has a toxic effect at high levels, and
therefore, it regulates NO levels with PDE5 inhibitors.
However, Elrod et al [28] reported that the protective ef-
fect of sildenafil may be independent of the NO/cGMP
pathway.
Our results showed significant increases in eNOS and
iNOS levels in the kidney tubular epithelium during renal I/
R, and these levels were significantly lower in the group
treated with tadalafil.
Guzeloglu et al [13] examined the effect of tadalafil on
renal I/R damage and histopathological and TAC changes in
tissue. Tadalafil regulates thrombocyte functions during I/R
damage and intracellular calcium ion levels [11]. Guzeloglu
et al [13] reported that TAC levels increased in the group
treated with tadalafil but that total oxidant capacity levels
were not different from those in a placebo group. They
observed that tadalafil exerted a protective effect on tis-
sues by increasing the antioxidant capacity. Similarly, we
observed that blood TAC levels decreased significantly in
the I/R group, but that this decrease was prevented by
administering tadalafil 1 hour before ischemia (I/R-T
group).
MDA is the end product of lipid peroxidation and is a
well-known marker for free radical formation in post-
ischemic tissue. Serarslan et al [29] determined that
tadalafil lowers MDA and superoxide dismutase levels but
increases levels of the antioxidant glutathione peroxide
during spinal cord damage. In our study, blood MDA levels
were decreased and TAC levels were increased in the
tadalafil-administered group, suggesting a protective ef-
fect. Tissue MDA levels were lower in the I/R-T group than
those in the I/R group, though the difference was not sig-
nificant. Similarly, tissue TAC levels increased with tadalafil
administration; however, the increase was not significant
when compared to that in the I/R group. We believe that
tadalafil should be injected intraperitoneally, rather than
orally, and that its duration of action must be kept short to
maximize efficacy.
A number of histological studies of I/R damage to kid-
neys and the effects of tadalafil have been conducted.
Tadalafil prevents renal injury 461Guzeloglu et al [13] determined that kidney tubular ne-
crosis, intracytoplasmic vacuolization in the tubular
epithelium, congestion, and mononuclear cell infiltration in
the interstitial region were minimal in a tadalafil-treated
group of I/R rats [13].
In our study, the histopathological changes included loss
of nuclei, cell swelling, cytoplasmic vacuolization, brush
border loss, tubular dilatation, hyaline cast formation in
the tubule lumen, interstitial congestion, and edema in the
kidney tubules of the cortex and medullary region of rats
treated with I/R. This renal damage was reduced in the
tadalafil-treated group compared with that in the I/R
group, with a meaningful decrease in renal damage scores.Conclusion
Because tadalafil reduced renal damage, it could be a good
alternative when clamping the aorta, particularly at the
level of the renal artery. Although animal studies do not
completely mimic the pathophysiology of renal I/R the
need for novel treatment strategies for this condition is
increasing because of the high mortality and morbidity
rates. This need will be met by researching the effective-
ness of agents that can reduce reperfusion damage.
We believe that studies on the protective effects of
tadalafil on I/R damage that include administration of the
drug at different times and by different methods will lead
to the proper application of tadalafil in clinical practice.References
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